Stockreport

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

Elicio Therapeutics, Inc.  (ELTX) 
PDF ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual Meeting 2024ELI-007 and ELI-008 preclinical data were accepted for a p [Read more]